Investing in the Future: A Role for Professional Societies to Prepare the Next Generation of Healthcare Leaders Through Curriculum Development and Dissemination.

antimicrobial stewardship curriculum education infectious diseases fellows professional society

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
07 09 2021
Historique:
received: 05 03 2021
pubmed: 18 3 2021
medline: 23 9 2021
entrez: 17 3 2021
Statut: ppublish

Résumé

Professional societies serve many functions that benefit constituents; however, few professional societies have undertaken the development and dissemination of formal, national curricula to train the future workforce while simultaneously addressing significant healthcare needs. The Infectious Diseases Society of America (IDSA) has developed 2 curricula for the specific purpose of training the next generation of clinicians to ensure the future infectious diseases (ID) workforce is optimally trained to lead antimicrobial stewardship programs and equipped to meet the challenges of multidrug resistance, patient safety, and healthcare quality improvement. A core curriculum was developed to provide a foundation in antimicrobial stewardship for all ID fellows, regardless of career path. An advanced curriculum was developed for ID fellows specifically pursuing a career in antimicrobial stewardship. Both curricula will be broadly available in the summer of 2021 through the IDSA website.

Identifiants

pubmed: 33730751
pii: 6175317
doi: 10.1093/cid/ciab244
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

911-918

Subventions

Organisme : Infectious Diseases Society of America

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Vera P Luther (VP)

Department of Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Rachel Shnekendorf (R)

Infectious Diseases Society of America, Arlington, Virginia, USA.

Ashleigh Logan (A)

Infectious Diseases Society of America, Arlington, Virginia, USA.

Sonali D Advani (SD)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Alice E Barsoumian (AE)

Infectious Disease Service, Brooke Army Medical Center, San Antonio, Texas, USA.

Cole Beeler (C)

Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Kenza Bennani (K)

Infectious Diseases Society of America, Arlington, Virginia, USA.

Kartikeya Cherabuddi (K)

Division of Infectious Diseases and Global Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.

Marisa Holubar (M)

Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Misha Huang (M)

Division of Infectious Diseases, University of Colorado, Aurora, Colorado, USA.

Dilek Ince (D)

Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.

Julie Ann Justo (JA)

Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, Columbia, South Carolina, USA.

Matthew S L Lee (MSL)

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Conan MacDougall (C)

Department of Clinical Pharmacy, University of California San Francisco School of Pharmacy, San Francisco, California, USA.

Priya Nori (P)

Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.

Christopher A Ohl (CA)

Department of Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Payal K Patel (PK)

University of Michigan Medical School, Ann Arbor, Michigan, USA.

Paul S Pottinger (PS)

University of Washington School of Medicine, Division of Allergy & Infectious Diseases, Seattle, Washington, USA.

Jennifer O Spicer (JO)

Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

Conor Stack (C)

Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Trevor C Van Schooneveld (TC)

Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Zachary I Willis (ZI)

Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH